Shanghai, China

Hou Wang

This inventor holds 1 USPTO granted patent. Top assignee: Shox Science Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hou Wang. Retrieved from https://idiyas.com/inventor/hou-wang-xgs8chgm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hou Wang

Introduction

Hou Wang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies against viral infections. His work is crucial in the ongoing fight against diseases such as COVID-19.

Latest Patents

Hou Wang holds a patent for "Antibodies Against SARS-CoV-2 Spike Protein." This innovation is vital for the development of therapeutic treatments and vaccines aimed at combating the COVID-19 pandemic. His patent portfolio reflects his commitment to advancing medical science and public health.

Career Highlights

Wang is associated with Shox Science Limited, a company dedicated to innovative scientific research and development. His role at the company allows him to leverage his expertise in antibody development and contribute to groundbreaking research in the field.

Collaborations

Throughout his career, Hou Wang has collaborated with notable scientists, including Richard A. Lerner and Guang Yang. These partnerships have enhanced his research capabilities and expanded the impact of his work in the scientific community.

Conclusion

Hou Wang's contributions to biotechnology, particularly through his patent on antibodies against SARS-CoV-2, highlight his role as an influential inventor. His work continues to inspire advancements in medical research and public health initiatives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…